-
平臺(tái)編號(hào)：bio-123145
-
細(xì)胞信息： OCI-Ly18
-
規(guī)格：1×10?cells/T25培養(yǎng)瓶
-
用途：細(xì)胞系
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類(lèi)或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
人彌漫大B淋巴瘤細(xì)胞
細(xì)胞名稱：人彌漫大B淋巴瘤細(xì)胞OCI-Ly18
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6：1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級(jí)：1
用途限制
僅供科研：2類(lèi)
培養(yǎng)體系：90%DMEM+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡(jiǎn)介：人彌漫大B淋巴瘤細(xì)胞OCI-Ly18取自56歲男性供體，該細(xì)胞源于DSMZ
注釋：From:Ontario Cancer Institute(OCI);Toronto;Canada.
Doubling time:~30-40 hours(DSMZ).
Omics:Array-based CGH.
Omics:CNV analysis.
Omics:miRNA expression profiling.
Omics:Transcriptome analysis.
Misspelling:OCI-LZ18;In BioSample SAMN03473448.
Misspelling:SU-DHL-18;In Cosmic 1295513.
Derived from sampling site:Pleural effusion.
基因突變：/
HLA信息：/
STR信息
Amelogenin X
CSF1PO 10,12
D5S818 11,12
D7S820 10,12
D13S317 10,12
D16S539 11,13
TH01 6,9
TPOX 8,11
vWA 15,19
參考文獻(xiàn)
PubMed=8574164;DOI=10.3109/10428199509059672
Chang H.,Blondal J.A.,Benchimol S.,Minden M.D.,Messner H.A.
p53 mutations,c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Leuk.Lymphoma 19:165-171(1995)
DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In)ISBN 9780122219702;pp.1-733;Academic Press;London(2001)
PubMed=11807979;DOI=10.1002/gcc.10025
Mehra S.,Messner H.A.,Minden M.D.,Chaganti R.S.K.
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.
Genes Chromosomes Cancer 33:225-234(2002)
PubMed=19278952;DOI=10.1182ood-2009-01-202028
Li C.,Kim S.-W.,Rai D.,Bolla A.R.,Adhvaryu S.,Kinney M.C.,Robetorye R.S.,Aguiar R.C.T.
Copy number abnormalities,MYC activity,and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
Blood 113:6681-6690(2009)
PubMed=26727417;DOI=10.3109/10428194.2015.1108414
Drexler H.G.,Eberth S.,Nagel S.,MacLeod R.A.F.
Malignant hematopoietic cell lines:in vitro models for double-hit B-cell lymphomas.
Leuk.Lymphoma 57:1015-1020(2016)
細(xì)胞操作說(shuō)明下載：細(xì)胞操作說(shuō)明
產(chǎn)品規(guī)格：T25培養(yǎng)瓶x1；1.5ml凍存管x2
細(xì)胞數(shù)量：1x10^6：1x10^6
保存溫度：37℃；-198℃
運(yùn)輸方式：常溫保溫運(yùn)輸；干冰運(yùn)輸
安全等級(jí)：1
用途限制
僅供科研：2類(lèi)
培養(yǎng)體系：90%DMEM+10%FBS+1%三抗
培養(yǎng)溫度：37℃
二氧化碳濃度：5%
簡(jiǎn)介：人彌漫大B淋巴瘤細(xì)胞OCI-Ly18取自56歲男性供體，該細(xì)胞源于DSMZ
注釋：From:Ontario Cancer Institute(OCI);Toronto;Canada.
Doubling time:~30-40 hours(DSMZ).
Omics:Array-based CGH.
Omics:CNV analysis.
Omics:miRNA expression profiling.
Omics:Transcriptome analysis.
Misspelling:OCI-LZ18;In BioSample SAMN03473448.
Misspelling:SU-DHL-18;In Cosmic 1295513.
Derived from sampling site:Pleural effusion.
基因突變：/
HLA信息：/
STR信息
Amelogenin X
CSF1PO 10,12
D5S818 11,12
D7S820 10,12
D13S317 10,12
D16S539 11,13
TH01 6,9
TPOX 8,11
vWA 15,19
參考文獻(xiàn)
PubMed=8574164;DOI=10.3109/10428199509059672
Chang H.,Blondal J.A.,Benchimol S.,Minden M.D.,Messner H.A.
p53 mutations,c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.
Leuk.Lymphoma 19:165-171(1995)
DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In)ISBN 9780122219702;pp.1-733;Academic Press;London(2001)
PubMed=11807979;DOI=10.1002/gcc.10025
Mehra S.,Messner H.A.,Minden M.D.,Chaganti R.S.K.
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.
Genes Chromosomes Cancer 33:225-234(2002)
PubMed=19278952;DOI=10.1182ood-2009-01-202028
Li C.,Kim S.-W.,Rai D.,Bolla A.R.,Adhvaryu S.,Kinney M.C.,Robetorye R.S.,Aguiar R.C.T.
Copy number abnormalities,MYC activity,and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
Blood 113:6681-6690(2009)
PubMed=26727417;DOI=10.3109/10428194.2015.1108414
Drexler H.G.,Eberth S.,Nagel S.,MacLeod R.A.F.
Malignant hematopoietic cell lines:in vitro models for double-hit B-cell lymphomas.
Leuk.Lymphoma 57:1015-1020(2016)
細(xì)胞操作說(shuō)明下載：細(xì)胞操作說(shuō)明
